跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CERDELGA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
CERDELGA
Authorized
STANDARD
CERDELGA
sanofi-aventis canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
73effed6d8957594
Company
sanofi-aventis canada inc
Type
Standard
Approval Details
Approval Id
73effed6d8957594
Drug Approval Canada Name
CERDELGA
Product Name
CERDELGA
Status
Marketed
Status Date
2024-10-14
Original Market Date
2017-07-26
Din
02463261
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
92:92.00
Atc Original
A16AX10 ELIGLUSTAT
Atc Name
a 16 ax 10
Aig Number
0158970001
Company Name
sanofi-aventis canada inc
Company Address
1755 Steeles Avenue West, Toronto, Ontario, Canada, M2R 3T4
Active Ingredients
ELIGLUSTAT (ELIGLUSTAT TARTRATE)
84 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
73effed6d8957594
Type
Standard
Back to Health Canada Approvals